Phreesia, Inc. (PHR) is a publicly traded Healthcare sector company. As of July 16, 2026, PHR trades at $10.89 with a market cap of $663.86M and a P/E ratio of 68.56. PHR moved +1.16% today. Year to date, PHR is -36.41%; over the trailing twelve months it is -59.75%. Its 52-week range spans $7.77 to $32.76. Analyst consensus is buy with an average price target of $13.83. Rallies surfaces PHR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest PHR news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $10.89 |
| Market Cap | $663.86M |
| P/E Ratio | 68.56 |
| EPS | $0.16 |
| Dividend Yield | 0.00% |
| 52-Week High | $32.76 |
| 52-Week Low | $7.77 |
| Volume | 332.30K |
| Avg Volume | 0 |
| Revenue (TTM) | $495.59M |
| Net Income | $9.18M |
| Gross Margin | 0.00% |
14 analysts cover PHR: 0 strong buy, 8 buy, 6 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $13.83.